BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 8871664)

  • 1. Reverse signaling via CD30 ligand.
    Wiley SR; Goodwin RG; Smith CA
    J Immunol; 1996 Oct; 157(8):3635-9. PubMed ID: 8871664
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CD30 ligand/CD30 plays a critical role in Th17 differentiation in mice.
    Sun X; Yamada H; Shibata K; Muta H; Tani K; Podack ER; Yoshikai Y
    J Immunol; 2010 Aug; 185(4):2222-30. PubMed ID: 20639486
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression of CD30 ligand (CD153) on murine activated T cells.
    Shimozato O; Takeda K; Yagita H; Okumura K
    Biochem Biophys Res Commun; 1999 Mar; 256(3):519-26. PubMed ID: 10080930
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A critical role of CD30 ligand/CD30 in controlling inflammatory bowel diseases in mice.
    Sun X; Somada S; Shibata K; Muta H; Yamada H; Yoshihara H; Honda K; Nakamura K; Takayanagi R; Tani K; Podack ER; Yoshikai Y
    Gastroenterology; 2008 Feb; 134(2):447-58. PubMed ID: 18242212
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CD30 antigen: not a physiological marker for TH2 cells but an important costimulator molecule in the regulation of the balance between TH1/TH2 response.
    Pellegrini P; Berghella AM; Contasta I; Adorno D
    Transpl Immunol; 2003; 12(1):49-61. PubMed ID: 14551032
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CD30-regulated apoptosis in murine CD8 T cells after cessation of TCR signals.
    Telford WG; Nam SY; Podack ER; Miller RA
    Cell Immunol; 1997 Dec; 182(2):125-36. PubMed ID: 9514701
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recombinant CD30 ligand and CD40 ligand share common biological activities on Hodgkin and Reed-Sternberg cells.
    Gruss HJ; Ulrich D; Braddy S; Armitage RJ; Dower SK
    Eur J Immunol; 1995 Jul; 25(7):2083-9. PubMed ID: 7621881
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression and regulation of CD30 ligand and CD30 in human leukemia-lymphoma cell lines.
    Gruss HJ; DaSilva N; Hu ZB; Uphoff CC; Goodwin RG; Drexler HG
    Leukemia; 1994 Dec; 8(12):2083-94. PubMed ID: 7528856
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Regulation of murine B cell growth and differentiation by CD30 ligand.
    Shanebeck KD; Maliszewski CR; Kennedy MK; Picha KS; Smith CA; Goodwin RG; Grabstein KH
    Eur J Immunol; 1995 Aug; 25(8):2147-53. PubMed ID: 7664777
    [TBL] [Abstract][Full Text] [Related]  

  • 10. T-cell activation by recombinant receptors: CD28 costimulation is required for interleukin 2 secretion and receptor-mediated T-cell proliferation but does not affect receptor-mediated target cell lysis.
    Hombach A; Sent D; Schneider C; Heuser C; Koch D; Pohl C; Seliger B; Abken H
    Cancer Res; 2001 Mar; 61(5):1976-82. PubMed ID: 11280755
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CD30: expression and function in health and disease.
    Horie R; Watanabe T
    Semin Immunol; 1998 Dec; 10(6):457-70. PubMed ID: 9826579
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterization of the CD30L binding domain on the human CD30 molecule using anti-CD30 antibodies.
    Franke AC; Jung D; Ellis TM
    Hybridoma; 2000 Feb; 19(1):43-8. PubMed ID: 10768840
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Deciphering CD30 ligand biology and its role in humoral immunity.
    Kennedy MK; Willis CR; Armitage RJ
    Immunology; 2006 Jun; 118(2):143-52. PubMed ID: 16771849
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CD30 ligand is a target for a novel biological therapy against colitis associated with Th17 responses.
    Sun X; Yamada H; Shibata K; Muta H; Tani K; Podack ER; Iwakura Y; Yoshikai Y
    J Immunol; 2010 Dec; 185(12):7671-80. PubMed ID: 21068411
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of tumour necrosis factor (TNF) ligand superfamily co-stimulatory molecules CD30L, CD27L, OX40L, and 4-1BBL in murine hearts with acute myocarditis caused by Coxsackievirus B3.
    Seko Y; Takahashi N; Oshima H; Shimozato O; Akiba H; Takeda K; Kobata T; Yagita H; Okumura K; Azuma M; Nagai R
    J Pathol; 2001 Dec; 195(5):593-603. PubMed ID: 11745696
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of CD30 and CD30 ligand in cultured cell lines from human germ-cell tumors.
    Pera MF; Bennett W; Cerretti DP
    Lab Invest; 1997 Apr; 76(4):497-504. PubMed ID: 9111512
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Structure and expression of murine CD30 and its role in cytokine production.
    Bowen MA; Lee RK; Miragliotta G; Nam SY; Podack ER
    J Immunol; 1996 Jan; 156(2):442-9. PubMed ID: 8543792
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Signalling via CD70, a member of the TNF family, regulates T cell functions.
    García P; De Heredia AB; Bellón T; Carpio E; Llano M; Caparrós E; Aparicio P; López-Botet M
    J Leukoc Biol; 2004 Jul; 76(1):263-70. PubMed ID: 15226368
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Human angiogenin fused to human CD30 ligand (Ang-CD30L) exhibits specific cytotoxicity against CD30-positive lymphoma.
    Huhn M; Sasse S; Tur MK; Matthey B; Schinköthe T; Rybak SM; Barth S; Engert A
    Cancer Res; 2001 Dec; 61(24):8737-42. PubMed ID: 11751393
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of the costimulatory receptor CD30 is regulated by both CD28 and cytokines.
    Gilfillan MC; Noel PJ; Podack ER; Reiner SL; Thompson CB
    J Immunol; 1998 Mar; 160(5):2180-7. PubMed ID: 9498756
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.